NCT07185035View on ClinicalTrials.gov

An Exploratory Clinical Study on the Safety and Efficacy of Autologous NK Cells in the Treatment of Pulmonary Nodules

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

September 20, 2026

Study Completion Date

September 20, 2027

Conditions
Pulmonary Nodules, SolitaryPulmonary Nodules, Multiple
Interventions
BIOLOGICAL

KN5001

"Subjects will receive KN5001 on day0, 3, and 6. Multiple Doses of KN5001 will infused using the 3 + 3 dose-escalation strategy."

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital with Nanjing Medical University, Nanjing

All Listed Sponsors
collaborator

Rui Therapeutics

UNKNOWN

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER